tradingkey.logo

Becton Dickinson and Co

BDX

175.500USD

+0.870+0.50%
終値 07/09, 16:00ET15分遅れの株価
50.30B時価総額
33.58直近12ヶ月PER

Becton Dickinson and Co

175.500

+0.870+0.50%
詳細情報 Becton Dickinson and Co 企業名
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
企業情報
企業コードBDX
会社名Becton Dickinson and Co
上場日Sep 25, 1963
設立日1906
最高経営責任者「CEO」Mr. Thomas E. Polen
従業員数74000
証券種類Ordinary Share
決算期末Sep 25
本社所在地One Becton Drive
都市FRANKLIN LAKES
証券取引所NYSE Consolidated
United States of America
郵便番号07417-1880
電話番号12018476800
ウェブサイトhttps://www.bd.com/
企業コードBDX
上場日Sep 25, 1963
設立日1906
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
754.64K
-0.32%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
47.02K
-3.86%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.21K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
Mr. Michael Feld
Mr. Michael Feld
Executive Vice President, President - Life Sciences
Executive Vice President, President - Life Sciences
9.19K
+38.45%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Director
Independent Director
9.14K
+11.33%
Ms. Michelle Quinn
Ms. Michelle Quinn
Executive Vice President, General Counsel
Executive Vice President, General Counsel
6.93K
+39.80%
Dr. Carrie L. Byington, M.D.
Dr. Carrie L. Byington, M.D.
Independent Director
Independent Director
5.25K
+21.54%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
754.64K
-0.32%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
47.02K
-3.86%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.21K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Medication Delivery Solutions
1.12B
21.19%
Medication Management Solutions
811.00M
15.38%
Pharmaceutical Systems
575.00M
10.91%
Peripheral Intervention
481.00M
9.12%
Integrated Diagnostic Solutions
456.00M
8.65%
Other
1.83B
34.75%
地域別USD
会社名
収益
比率
United States
3.11B
58.93%
International
2.16B
41.05%
事業別
地域別
事業別USD
会社名
収益
比率
Medication Delivery Solutions
1.12B
21.19%
Medication Management Solutions
811.00M
15.38%
Pharmaceutical Systems
575.00M
10.91%
Peripheral Intervention
481.00M
9.12%
Integrated Diagnostic Solutions
456.00M
8.65%
Other
1.83B
34.75%
株主
更新時刻: Thu, May 15
更新時刻: Thu, May 15
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.27%
BlackRock Institutional Trust Company, N.A.
5.16%
State Street Global Advisors (US)
4.88%
T. Rowe Price Investment Management, Inc.
4.39%
T. Rowe Price Associates, Inc.
3.80%
Other
70.50%
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.27%
BlackRock Institutional Trust Company, N.A.
5.16%
State Street Global Advisors (US)
4.88%
T. Rowe Price Investment Management, Inc.
4.39%
T. Rowe Price Associates, Inc.
3.80%
Other
70.50%
種類
株主統計
比率
Investment Advisor
41.25%
Investment Advisor/Hedge Fund
40.93%
Hedge Fund
3.21%
Research Firm
2.94%
Pension Fund
2.75%
Bank and Trust
1.65%
Sovereign Wealth Fund
1.23%
Individual Investor
0.57%
Insurance Company
0.30%
Other
5.17%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
比率
保有株式数
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
2825
272.14M
94.95%
-10.12M
2025Q1
2897
269.10M
93.89%
-12.90M
2024Q4
2874
271.53M
94.56%
-4.62M
2024Q3
2787
266.29M
92.14%
-3.20M
2024Q2
2782
261.01M
90.31%
-2.68M
2024Q1
2797
255.99M
88.58%
-10.13M
2023Q4
2783
259.38M
89.78%
-7.79M
2023Q3
2768
264.64M
91.23%
-591.87K
2023Q2
2787
263.29M
90.78%
-570.64K
2023Q1
2795
257.22M
90.56%
-8.75M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
32.31M
11.27%
+4.44M
+15.92%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
14.79M
5.16%
-22.91K
-0.15%
Mar 31, 2025
State Street Global Advisors (US)
13.99M
4.88%
-94.83K
-0.67%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
12.58M
4.39%
+448.64K
+3.70%
Mar 31, 2025
T. Rowe Price Associates, Inc.
10.89M
3.8%
-1.04M
-8.70%
Mar 31, 2025
Geode Capital Management, L.L.C.
6.48M
2.26%
+127.97K
+2.01%
Mar 31, 2025
MFS Investment Management
6.11M
2.13%
+655.88K
+12.02%
Mar 31, 2025
First Eagle Investment Management, L.L.C.
5.52M
1.93%
+1.09M
+24.64%
Mar 31, 2025
Generation Investment Management LLP
5.30M
1.85%
-518.93K
-8.92%
Mar 31, 2025
Morgan Stanley Investment Management Ltd. (UK)
4.96M
1.73%
-737.71K
-12.95%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sun, Jul 6
更新時刻: Sun, Jul 6
銘柄名
比率
iShares U.S. Medical Devices ETF
4.36%
American Century Focused Large Cap Value ETF
3.16%
First Eagle Global Equity ETF
3.14%
T Rowe Price Capital Appreciation Equity ETF
3.11%
Franklin ClearBridge Enhanced Income ETF
2.93%
iShares Large Cap Value Active ETF
2.34%
Running Oak Efficient Growth ETF
1.9%
SPDR S&P Health Care Equipment ETF
1.8%
T Rowe Price Equity Income ETF
1.72%
First Trust Indxx Medical Devices ETF
1.61%
詳細を見る
iShares U.S. Medical Devices ETF
比率4.36%
American Century Focused Large Cap Value ETF
比率3.16%
First Eagle Global Equity ETF
比率3.14%
T Rowe Price Capital Appreciation Equity ETF
比率3.11%
Franklin ClearBridge Enhanced Income ETF
比率2.93%
iShares Large Cap Value Active ETF
比率2.34%
Running Oak Efficient Growth ETF
比率1.9%
SPDR S&P Health Care Equipment ETF
比率1.8%
T Rowe Price Equity Income ETF
比率1.72%
First Trust Indxx Medical Devices ETF
比率1.61%
配当金
過去5年間の配当金総支払額は 5.34B 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Jan 28, 2025
BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Mar 31, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 31, 2025
Mar 10, 2025
Nov 07, 2024
BDX.NB Final Cash Dividend of gross USD 1.04 paid on Dec 31, 2024 going ex on Dec 09, 2024
Dec 09, 2024
Dec 31, 2024
Dec 09, 2024
Jul 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Sep 30, 2024 going ex on Sep 09, 2024
Sep 09, 2024
Sep 30, 2024
Sep 09, 2024
Apr 30, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Jun 28, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 28, 2024
Jun 10, 2024
Jan 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Mar 29, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 29, 2024
Mar 07, 2024
Nov 09, 2023
BDX.NB Final Cash Dividend of gross USD 0.95 paid on Dec 29, 2023 going ex on Dec 07, 2023
Dec 08, 2023
Dec 29, 2023
Dec 07, 2023
Jul 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Sep 29, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 29, 2023
Sep 07, 2023
Apr 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Jun 30, 2023 going ex on Jun 08, 2023
Jun 09, 2023
Jun 30, 2023
Jun 08, 2023
Jan 24, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Mar 31, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 31, 2023
Mar 09, 2023
Nov 10, 2022
BDX.NB Final Cash Dividend of gross USD 0.91 paid on Dec 30, 2022 going ex on Dec 08, 2022
Dec 09, 2022
Dec 30, 2022
Dec 08, 2022
詳細を見る
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
tradingkey.logo
tradingkey.logo
当社が提供する日中データはRefinitivより配信されており、同社の利用規約が適用されます。終値データ(過去・現在)についてもRefinitivより提供されています。全ての相場情報は現地取引所時間で表示されます。米国株式のリアルタイム最終取引価格はNasdaqを通じて報告された取引のみを反映しています。日中データは最低15分遅れ、または各取引所の要件に準じて遅延配信されます。
* 当コンテンツ(分析資料・取引戦略等)は第三者プロバイダーであるTrading Centralより提供されており、記載の見解は分析官の独立した評価及び判断に基づくものです。投資家個々の投資目的や財務状況は考慮されておりません。
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。
KeyAI